|
Volumn 133, Issue 9, 2013, Pages 2135-2137
|
Skin-specific drug delivery: A rapid solution to skin diseases?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DERMATOLOGICAL AGENT;
DESMOGLEIN 3;
DESMOGLEIN 3 ANTIBODY;
IMMUNOSUPPRESSIVE AGENT;
METHOTREXATE;
NEW DRUG;
SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY;
TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;
ANTIGEN EXPRESSION;
APOPTOSIS;
AUTOIMMUNE DISEASE;
CELL CONTACT;
DERMATITIS;
DRUG BIOAVAILABILITY;
DRUG DELIVERY SYSTEM;
DRUG TARGETING;
HOST RESISTANCE;
HUMAN;
IMMUNE RESPONSE;
IMMUNOSUPPRESSIVE TREATMENT;
KERATINOCYTE;
LEUKEMIA CELL;
LICHEN PLANUS;
NONHUMAN;
PATHOGENESIS;
PEMPHIGUS VULGARIS;
PRECANCER;
PRIORITY JOURNAL;
PSORIASIS;
REVIEW;
SKIN CANCER;
SKIN DISEASE;
TARGET ORGAN;
|
EID: 84884386338
PISSN: 0022202X
EISSN: 15231747
Source Type: Journal
DOI: 10.1038/jid.2013.231 Document Type: Note |
Times cited : (6)
|
References (8)
|